Nuclear Medicine

Research Frontiers in Breast Cancer Receptor Targeting

Development of estrogen receptor, progesterone receptor, and HER2-targeted radiopharmaceuticals for prediction of endocrine therapy and trastuzumab response.

All Nuclear Medicine PhD categories